DOI: http://dx.doi.org/10.18203/issn.2454-5929.ijohns20195695

Role of topical intranasal steroids in pediatric hearing loss due to otitis media with effusion: the experiences

Santosh Kumar Swain, Ishwar Chandra Behera, Rohit Agrawala, Nibi Shajahan

Abstract


Background: Otitis media with effusion (OME) is one of the commonest diseases causing hearing impairment in children. Hearing loss in early childhood may lead to risk of speech and language problems and psychosocial abnormalities. Aim of this study is to evaluate the role of topical intranasal steroids (Mometasone furoate) in pediatric hearing loss due to otitis media with adenoid hypertrophy.

Methods: A prospective study carried out at a tertiary care teaching hospital of eastern India where 104 children participated with diagnosis of otitis media with effusion and hearing loss between 2017 to 2019. These participants were divided into study group and control group. The age group of the children was between 5 to 10 years. Detail otoscopic examination, pure tone audiometry, tympanometry and nasopharyngeal endoscopy were done for assessing the hearing loss, fluid in the middle ear and adenoid hypertrophy.  

Results: There is improvement of hearing in the study group as compared to control group. A significant improvement in hearing was seen in the study group (p=0.0001). In the study group, 37 (77.08%) out of the 48 children OME resolved over a period of 12 weeks after treatment in comparison to 18 (37.50%) in the control group (p=0.0004).

Conclusions: Intranasal topical steroids can be a treatment option alternative to surgery in OME. As it is short term follow up in this study, long term follow up is required. Intranasal mometasone furoate treatment can be considered as a good treatment option for OME.


Keywords


Adenoid hypertrophy, Hearing loss, Otitis media with effusion, Pediatric patients

Full Text:

PDF

References


Williamson IG, Dunleavey J, Bain J, Robinson D. The natural history of otitis media with effusion - a three-year study. J Laryngol Otol. 1994;108:930-4.

Ungkanont K, Boonyabut P, Komoltri C, Tanphaichitr A, Vathanophas V. Surveillance of otitis media with effusion in Thai children with cleft palate: Cumulative incidence and outcome of the management. Cleft Palate-Craniofacial J. 2018;55(4):590-5.

Orlando MP, Bonanno MA, Russo FY, Ralli M, Turchetta R, Passali FM, et al. Correlation between otitis media with effusion and cranial deformation in children. Euro Rev Med Pharmacol Sci. 2019;23(1):55-9.

Casselbrant ML, Brostoff LM, Flaherty MR, Bluestone CD, Cantekin EI, Doyle WJ, et al. Otitis media with effusion in preschool children. Laryngo. 1985;95(4):428-36.

Tankel JW, Cheesman AD. Symptom relief by adenoidectomy and relationship to adenoid and post-nasal airway size. J Laryngol Otol. 1986;100(6):637-40.

Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Inter J Pediatr Otorhinolaryngol. 2006 Apr 1;70(4):639-45.

Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray. Drug Safety. 2007;30(4):317-26.

Bluestone CD, Gates GA, Klein JO, Lim DJ, Mogi G, Ogra PL, et al. Definitions, terminology, and classification of otitis media. Annals Otol, Rhinol Laryngol. 2002;111(3_suppl):8-18.

Pichichero ME. Helping children with hearing loss from otitis media with effusion. Lancet. 2018;392(10147):533-4.

Lee A. Re: the role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol. 2007;71(2):358.

Poliakova SD, Popova EA. Effectiveness criteria for the topical application of glucocorticosteroids to the treatment of exudative otitis media associated with allergic rhinitis. Vestnik otorinolaringologii. 2010;5:32-4.

Goldbart AD, Veling MC, Goldman JL, Li RC, Brittian KR, Gozal D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnoea. Pediatr Res. 2005;57:232-6.

Wang DE, Lam DJ, Bellmunt AM, Rosenfeld RM, Ikeda AK, Shin JJ. Intranasal steroid use for otitis media with effusion: ongoing opportunities for quality improvement. Otolaryngol Head Neck Surg. 2017;157(2):289-96.

Ciprandi G, Varricchio A, Capasso M, Varricchio AM, De Lucia A, Ascione E, Avvisati F, Capristo C, Marseglia GL, Barillari U. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol. 2007;20(4):833-6.

Bitar MA, Mahfoud L, Nasar J, Dana R. Exploring the characteristics of children with obstructive adenoid responding to mometasone furoate monohydrate: preliminary results. Eur Arch Otorhinolaryngol. 2013;270:931-7.

Baptista A. Does early identification of children with otitis media with effusion can prevent difficulties in language development? Euro J Public Health. 2019;29(Supplement_1):ckz034-019.

Feng W, Sun R, Guo D, Yuan W. Retrograde Catheteration via Eustachian tube and ambroxol hydrochloride injection for secretory otitis media. Chin Arch Otolaryngol Head Neck Surg. 2007;14(8): 456-7.

Rosenfeld RM. New concepts for steroid use in otitis media with effusion. Clini Pediatr. 1992;31(10):615-21.

Lepcha A, Kurien M, Job A, Jeyaseelan L, Thomas K. Chronic adenoid hypertrophy in children—is steroid nasal spray beneficial? Indian J Otolaryngol Head Neck Surg. 2002;54(4):280-4.

Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Annals Allergy, Asthma Immunol. 1998;80(2):198-206.

Mohamed MA, Aleabiary HA, Hassan MA, Elsersy HA. The role of topical nasal steroid in treatment of otitis media with effusion in children: systematic review. Egyptian J Hospital Med. 2018;70(4):559-69.

Berlucchi M, Salsi D, Valetti L, Parrinello G, Nicolai P. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatr. 2007;119(6):e1392-7.

Yildirim YS, Senturk E, Eren SB, Dogan R, Tugrul S, Ozturan O. Efficacy of nasal corticosteroid in preventing regrowth after adenoidectomy. Auris Nasus Larynx. 2016;43(6):637-40.

Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatr. 1995;95(3):355-64.

Swain SK, Samal R, Pani SK. Effect of smoking on outcome of tympanoplasty. Ind J Otol. 2011;17(3):120.

Alexopoulos EI, Kaditis AG, Kalampouka E, Kostadima E, Angelopoulos NV, Mikraki V, Skenteris N, Gourgoulianis K. Nasal corticosteroids for children with snoring. Pediatric Pulmonol. 2004;38(2):161-7.